PPD

Adding cell and gene therapy capabilities to support growing customer need WILMINGTON, N.C. – PPD, Inc. (Nasdaq: PPD), a leading global contract research organization, is expanding its Athlone, Ireland, GMP (good manufacturing practices) laboratory, significantly increasing the size of its current facility and adding cell and gene therapy testing to the operation’s portfolio of services. The expansion…

Read More